Sandbox Reserved 467

This Sandbox is Reserved from 13/03/2012, through 01/06/2012 for use in the course "Proteins and Molecular Mechanisms" taught by Robert B. Rose at the North Carolina State University, Raleigh, NC USA. This reservation includes Sandbox Reserved 451 through Sandbox Reserved 500.

To get started: Click the edit this page tab at the top. Save the page after each step, then edit it again. Click the 3D button (when editing, above the wikitext box) to insert Jmol. show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page. Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc. More help: Help:Editing For more help, look at this link: http://www.proteopedia.org/wiki/index.php/Help:Getting_Started_in_Proteopedia Cyclin-Dependent Kinase 3Cyclin-Dependent Kinase 3 INTRODUCTIONINTRODUCTION Cyclin-dependent kinase (Cdk) is a protein kinase family involved in regulation of the cell cycle. These Cdks are relatively small protein enzymes are responsible for mitosis, specifically transcriptional activity. They help activate DNA repair by being inhibited through phosphorylation during DNA damage response (DDR). They are also generally inactive during checkpoints along the cell cycle. More than one Cdk can be in charge of different phases of the cell cycle. Often times, DDR is controlled by overall level of Cdk activity, and not by individual Cdks . CDKs are activated through physical association with cyclin, a family of proteins, in which their abundance and proteolysis pattern within the cell vary according to the stage of cell cycle. Major transitions in the cell cycle are caused by activation of CDKs 1-4, which causes phosphorylation and dephosphorylation of key residues. Cells enter mitosis as protein-bound phosphates increase (Hames et al., 1998). In mammalian cells, it had been suggested that CDK-3, along with CDK-2, are required for G1/S stage (Hutchison p.111). Compared to CDK-1, 2, and 4, the role of CDK-3 is still unclear, as no cyclin partner had been found for it. However, it had been shown that it delays cells in the G1 phase (Hutchison, p.149). Cdk’s are found in Eukaryotes, including human and yeast cells. Each organism has a different number of Cdks. In yeast, there is less, and more in humans. It is easier to study which Cdk is responsible for which part of the cell cycle in yeast than in humans, because of the level of complexity of Cdk and other cell activities in Homo Sapiens . Based on the molecular model, the overall structure of human CDK-3 was found to contain 305 amino acid residues, with a total molecular weight of 35,045.74 Da, and a theoretical pI of 8.86. Many features of secondary structure and molecular fork was found to very much resemble CDK-2 . Human CDK-3 proteins was found to have alpha and beta structures. Its fold contains two alpha and two beta domains, with a larger C-terminal that is mostly alpha helical (this is characteristic of a typical protein kinase fold). CDK-3 is found to be folded into a bilobal structure, with smaller N-terminal lobe that is mostly β-sheet structure . The N-terminal lobe is found in a sheet of 5 antiparallel β-strands (β1-β5), and in one, large alpha helix (α-1). The C-terminal domain contains pseudo-4-helical bundle (α-2 to α-3, α-6), small β-ribbon (β-6 to β-8), and 2 alpha helices (α-5, α-7) . The ATP binding pocket is found in the cleft in between the bilobal structure. Most residues found in the ATP binding pocket is hydrophobic. The hydrophobic pocket can fit in different geometries of residues, like adenine derivatives and flavonoids . BINDINGBINDING Binding between CDK3 and inhibitors at the molecular fork require intermolecular hydrogen bonds. They are responsible for specificity and affinity between the protein and its ligand. A common pattern of this is shared with CDK2. At the molecular fork, or where inhibitors and ATP can bind, it is determined so far that an acceptor close to N-H in Leu83 and 1 H-bond donor close to C=O in Glu81 and/or Leu83 are present . Although specific contact areas are not yet concluded, a high correlation coefficient between CDK-3 and CDK-2 pkd values suggest that CDK-2 inhibitors can also inhibit CDK-3. Pkd values for various known CDK-2 inhibitors with were analyzed in its interaction with CDK-3, and 4 inhibitors were shown to be the best: - n-methyl-{4-[2-(7-oxo-6, 7-dihydro-8h-[1,3]thiazolo[5,4-e] indol-8-ylidene) hydrazine]phenyl}methanesulfonamide - (2r)-1-(dimethylamino)-3-{4-[6-{[2-fluoro-5-(trifluoromethyl)phenyl] amino}pyrimidin-4-yl)amino]phenoxy}propan-2-ol - (5-chloropyrazolo[1,5-a]pyrimidin-7-yl)-(4-methanesulfonylphenyl)amine - din-232306 6-(3,4-dihydroxybenzyl)-3-ethyl-1-(2,4,6-trichlorophenyl-1h-pyrazolo[3,4-d]pyrimidin-4(5h)-one MOLECULAR DYNAMICSMOLECULAR DYNAMICS Molecular dynamics of human CDK-3 protein model was assessed by RMSF values. Backbone fluctuations, or residues of higher flexibility, occur in loop and turn regions of residues that surround the alpha-beta-alpha fold. Relatively high RMSF values are found in more flexible regions in the CDK-3 structure. These regions are: L1 (turn composed of Glu25- Gly27), L2 (loop Leu37- Pro45), L3 (turn Glu73- Arg74), L4 (loop Thr94- Pro100), L5 (turn Tyr159- His161), and L6 (loop Gly220- Gly247) . MEDICAL IMPLICATIONMEDICAL IMPLICATION REFERENCESREFERENCES Perez, Patricia C., Rafael A. Cacerez, Fernanda Canduri, and Walter F. Azevedo. "Molecular Modeling and Dynamics Simulation of Human Cyclin-dependent Kinase 3 Complexed with Inhibitors." Computers in Biology and Medicine 39(2008): 130-140. PubMed. Web. 1 May 2012. PMID: 19152876 doi:10.1016/j.compbiomed.2008.11.004 FOOTNOTESFOOTNOTES